Search: onr:"swepub:oai:DiVA.org:umu-26435" >
Sequence variants a...
Sequence variants at 22q13 are associated with prostate cancer risk.
- Article/chapterEnglish2009
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:DiVA.org:umu-26435
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-26435URI
-
https://doi.org/10.1158/0008-5472.CAN-08-3464DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:118070529URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
To search for genetic variants that are associated with prostate cancer risk in the genome, we combined the data from our genome-wide association study (GWAS) in a population-based case-control study in Sweden with publicly available GWAS data from the Cancer Genetic Markers of Susceptibility (CGEMS) study. We limited the cases to those with aggressive disease in an attempt to identify risk variants that are associated with this most clinically relevant form of the disease. Among the most likely candidate single nucleotide polymorphisms (SNP) identified from the two GWAS, we sequentially confirmed one SNP at 22q13 in two independent study populations: the remaining subjects in Cancer of the Prostate in Sweden and a hospital-based case-control study at Johns Hopkins Hospital. Association of aggressive prostate cancer with the SNP at 22q13 was also observed in the publicly available data of four additional study populations from the second stage of the CGEMS study. In all seven study populations examined, the frequency of allele "C" of rs9623117 at 22q13 was consistently higher in aggressive cases than in controls. The combined allelic test was highly significant, with P = 5.0 x 10(-7). The odds ratio (OR) of allele C for aggressive prostate cancer was estimated to be 1.18 [95% confidence interval (95% CI), 1.11-1.26]. However, the SNP was also associated with nonaggressive prostate cancer, with an estimated OR of 1.11 (95% CI, 1.04-1.19; P = 0.004). The risk-associated variants are located within the genomic region of TNRC6B, a gene involved in miRNA-mediated mRNA degradation. Additional studies are warranted to further confirm the association.
Added entries (persons, corporate bodies, meetings, titles ...)
-
Zheng, Siqun Lilly
(author)
-
Wiklund, FredrikKarolinska Institutet
(author)
-
Isaacs, Sarah D
(author)
-
Li, Ge
(author)
-
Wiley, Kathleen E
(author)
-
Kim, Seong-Tae
(author)
-
Zhu, Yi
(author)
-
Zhang, Zheng
(author)
-
Hsu, Fang-Chi
(author)
-
Turner, Aubrey R
(author)
-
Stattin, PärUmeå universitet,Urologi och andrologi(Swepub:umu)past0003
(author)
-
Liu, Wennuan
(author)
-
Kim, Jin Woo
(author)
-
Duggan, David
(author)
-
Carpten, John
(author)
-
Isaacs, William
(author)
-
Grönberg, HenrikKarolinska Institutet
(author)
-
Xu, Jianfeng
(author)
-
Chang, Bao-Li
(author)
-
Karolinska InstitutetUrologi och andrologi
(creator_code:org_t)
Related titles
-
In:Cancer research69:1, s. 10-51538-7445
Internet link
Find in a library
To the university's database
- By the author/editor
-
Sun, Jielin
-
Zheng, Siqun Lil ...
-
Wiklund, Fredrik
-
Isaacs, Sarah D
-
Li, Ge
-
Wiley, Kathleen ...
-
show more...
-
Kim, Seong-Tae
-
Zhu, Yi
-
Zhang, Zheng
-
Hsu, Fang-Chi
-
Turner, Aubrey R
-
Stattin, Pär
-
Liu, Wennuan
-
Kim, Jin Woo
-
Duggan, David
-
Carpten, John
-
Isaacs, William
-
Grönberg, Henrik
-
Xu, Jianfeng
-
Chang, Bao-Li
-
show less...
- Articles in the publication
-
Cancer research
- By the university
-
Umeå University
-
Karolinska Institutet